Real-Time OneStep RT-PCR based assay system for detection of COVID19(DiaPlexQ Novel Coronavirus Detection kit CV-IVD)
- UID
- IMP/IVD/2020/000994_85f6e8cf7a049273ca2dce8fc86203d0_bd2440522e552694a42b047075841430
- Device class
- Class C
- Brand name
- 2019-nCoV
- License holder
- Shree Venkatesh Medical Agencies
- Approving authority
- CDSCO
- Product information
- The DiaPlexQ Novel Coronavirus (2019-nCoV) detection Kit is a real-time reverse transcriptase (2019-nCoV) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs, sputum from individuals suspected of COVID-19.
Real-Time OneStep RT-PCR based assay system for detection of COVID19(DiaPlexQ Novel Coronavirus Detection kit CV-IVD) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000994_85f6e8cf7a049273ca2dce8fc86203d0_bd2440522e552694a42b047075841430. This device is marketed under the brand name 2019-nCoV. The license holder is Shree Venkatesh Medical Agencies, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.